Lorenzo Alonso

582 total citations
20 papers, 461 citations indexed

About

Lorenzo Alonso is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Lorenzo Alonso has authored 20 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Lorenzo Alonso's work include Ovarian cancer diagnosis and treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Lorenzo Alonso is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Lorenzo Alonso collaborates with scholars based in Spain, United States and Switzerland. Lorenzo Alonso's co-authors include Emilio Alba, Javier Márquez, Juan Segura, José A. Campos‐Sandoval, Carolina Lobo, José M. Matés, Francisco J. Alonso, Elísabeth Pérez-Ruiz, J.M. Jurado and Begoña Mellado and has published in prestigious journals such as Cancer, Annals of Oncology and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Lorenzo Alonso

20 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenzo Alonso Spain 10 187 165 106 99 66 20 461
Carina Pereira Portugal 13 163 0.9× 115 0.7× 106 1.0× 134 1.4× 63 1.0× 31 453
Manon de Ladurantaye Canada 13 265 1.4× 156 0.9× 51 0.5× 129 1.3× 42 0.6× 17 574
Tatiana de Almeida Simão Brazil 14 316 1.7× 115 0.7× 86 0.8× 108 1.1× 59 0.9× 28 475
Seraina Faes Switzerland 12 370 2.0× 156 0.9× 67 0.6× 149 1.5× 68 1.0× 23 628
Mingjing He China 16 443 2.4× 194 1.2× 61 0.6× 95 1.0× 88 1.3× 26 723
Songlin Peng China 7 250 1.3× 213 1.3× 54 0.5× 146 1.5× 62 0.9× 17 507
Zhao Yin-nong China 10 156 0.8× 114 0.7× 99 0.9× 112 1.1× 42 0.6× 24 406
Kakil Ibrahim Rasul Qatar 9 183 1.0× 192 1.2× 63 0.6× 122 1.2× 116 1.8× 48 495
H. W. Verspaget Netherlands 11 173 0.9× 154 0.9× 130 1.2× 153 1.5× 54 0.8× 24 586
Ayshamgul Hasim China 15 387 2.1× 105 0.6× 60 0.6× 206 2.1× 48 0.7× 38 613

Countries citing papers authored by Lorenzo Alonso

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Alonso more than expected).

Fields of papers citing papers by Lorenzo Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Alonso. The network helps show where Lorenzo Alonso may publish in the future.

Co-authorship network of co-authors of Lorenzo Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Alonso. A scholar is included among the top collaborators of Lorenzo Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Alonso. Lorenzo Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez-Ruiz, Elísabeth, Antonio Rueda, Francisco Rivas‐Ruiz, et al.. (2017). Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pathology & Oncology Research. 24(4). 871–879. 3 indexed citations
2.
Arance, Ana, Alfonso Berrocal, José A. López-Martín, et al.. (2016). Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience. Clinical & Translational Oncology. 18(11). 1147–1157. 17 indexed citations
3.
Martín‐Algarra, Salvador, Vincent Soriano, Josep Malvehy, et al.. (2014). Treatment Patterns of Adjuvant Interferon Alfa-2B (Ifn-&Agr;2B) for High-Risk Melanoma. a Retrospective Study of the Grupo Español Multidisciplinar De Melanoma (Gem). Annals of Oncology. 25. iv389–iv389. 1 indexed citations
4.
Berrocal, Alfonso, Ana Arance, José A. López-Martín, et al.. (2014). Ipilimumab for advanced melanoma. Melanoma Research. 24(6). 577–583. 32 indexed citations
5.
Alonso, Lorenzo, et al.. (2010). ¿Diagnosticar mejor? Savia nueva para un árbol viejo. Medicina Clínica. 137(12). 561–564. 3 indexed citations
6.
Sánchez‐Muñoz, Alfonso, Javier de la Cruz, Claudio Ballestı́n, et al.. (2009). Negative Prognostic Impact of the Coexpression of Epidermal Growth Factor Receptor and c-erbB-2 in Locally Advanced Cervical Cancer. Oncology. 76(2). 133–141. 33 indexed citations
7.
Alonso, Lorenzo, et al.. (2009). Gonadotropin and steroid receptors as prognostic factors in advanced ovarian cancer: a retrospective study. Clinical & Translational Oncology. 11(11). 748–752. 8 indexed citations
8.
Matés, José M., Juan Segura, José A. Campos‐Sandoval, et al.. (2009). Glutamine homeostasis and mitochondrial dynamics. The International Journal of Biochemistry & Cell Biology. 41(10). 2051–2061. 126 indexed citations
9.
Jurado, J.M., et al.. (2008). Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer. Clinical & Translational Oncology. 10(9). 583–586. 54 indexed citations
10.
Jurado, J.M., et al.. (2008). Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer. Clinical & Translational Oncology. 10(11). 772–772. 3 indexed citations
11.
González, Francisco Javier, Luís Vicioso, Martina Álvarez, et al.. (2007). Association between VEGF expression in tumour-associated macrophages and elevated serum VEGF levels in primary colorectal cancer patients. Cancer Biomarkers. 3(6). 325–333. 12 indexed citations
12.
González, Francisco Javier, A. Rueda, Isabel Sevilla, et al.. (2004). Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation. The International Journal of Biological Markers. 19(3). 221–228. 23 indexed citations
13.
Hierro, Isabel del, et al.. (2004). Relación entre la exposición a pesticidas y el desarrollo de carcinoma urotelial vesical superficial de bajo grado. Medicina Clínica. 123(15). 571–574. 6 indexed citations
14.
Hierro, Isabel del, et al.. (2004). Relación entre la exposición a pesticidas y el desarrollo de carcinoma urotelial vesical superficial de bajo grado. Medicina Clínica. 123(15). 571–574. 1 indexed citations
15.
González, Francisco Javier, A. Rueda, Isabel Sevilla, et al.. (2004). Shift in the Balance between Circulating Thrombospondin-1 and Vascular Endothelial Growth Factor in Cancer Patients: Relationship to Platelet α-Granule Content and Primary Activation. The International Journal of Biological Markers. 19(3). 221–228. 7 indexed citations
16.
Carles, Joan, A. Arriví, Óscar Juan, et al.. (2003). Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract. Cancer. 97(9). 2180–2186. 83 indexed citations
17.
Alba, Emilio, Nuria Ribelles, Isabel Sevilla, et al.. (2001). Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer. Breast Cancer Research and Treatment. 66(1). 33–39. 15 indexed citations
18.
Sievers, Martin, et al.. (1996). 16S-23S ribosomal RNA spacer regions ofAcetobacter europaeusandA. xylinum, tRNA genes and antitermination sequences. FEMS Microbiology Letters. 142(1). 43–48. 23 indexed citations
19.
Alba, Emilio, Miguel Ángel Sánchez-Chaparro, Lorenzo Alonso, et al.. (1996). Cisplatin, 5-Fluorouracil, and High-Dose Folinic Acid in Patients with Advanced Unresectable Head and Neck Cancer. American Journal of Clinical Oncology. 19(2). 140–143. 3 indexed citations
20.
Alba, Emilio, et al.. (1992). Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. Annals of Oncology. 3(1). 31–35. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carina Pereira Breakdown of academic impact, for papers by Manon de Ladurantaye Breakdown of academic impact, for papers by Tatiana de Almeida Simão Breakdown of academic impact, for papers by Seraina Faes Breakdown of academic impact, for papers by Mingjing He Breakdown of academic impact, for papers by Songlin Peng Breakdown of academic impact, for papers by Zhao Yin-nong Breakdown of academic impact, for papers by Kakil Ibrahim Rasul Breakdown of academic impact, for papers by H. W. Verspaget Breakdown of academic impact, for papers by Ayshamgul Hasim
Rankless by CCL
2026